Pharmacokinetic-Pharmacodynamic Modeling Approach for Dose Prediction of the Optimal Long-Acting Injectable Formulation of Finasteride

March 2021 in “ International Journal of Pharmaceutics ”

Dong-Hyun Kang, Choong-Min Ryu, Ju Han Kim, Go-Wun Choi, Se-Yeon Kim, Chan Hee Chon, Hea-Young Cho

finasteride long-acting injectable hair loss pharmacokinetic-pharmacodynamic modeling PLGA 7525A microspheres repeat dose toxicity Propecia

TLDR Optimal long-acting finasteride injection dose found: 16.8 mg, effective for one month.

This document discusses a study that developed a long-acting injectable form of finasteride for treating hair loss and created a model to predict the optimal dosage using pharmacokinetic-pharmacodynamic modeling. The study tested different ratios and conditions to create finasteride-loaded microspheres and found that PLGA 7525A was effective in maintaining a suitable drug concentration level for one month. The optimal dose was found to be 16.8 mg based on predicted PK-PD profiles. The study also conducted repeat dose toxicity tests on male beagle dogs and found no serious toxicological signs.

View this study on sciencedirect.com →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date

32 citations, March 2020 in “Drug Design Development and Therapy”

Finasteride shows promise for female hair loss, but more research needed.

research Optimization of Microstructured Biodegradable Finasteride Formulation for Depot Parenteral Application

6 citations, February 2016 in “Journal of Microencapsulation”

Improved finasteride formula allows slow, sustained release and better absorption for patients.

research Assessment of the Usefulness of Dihydrotestosterone in the Diagnostics of Patients with Androgenetic Alopecia

35 citations, January 2014 in “Postepy Dermatologii I Alergologii”

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

research Finasteride, a Type 2 5α-Reductase Inhibitor, in the Treatment of Men with Androgenetic Alopecia

32 citations, April 1999 in “Expert Opinion on Investigational Drugs”

Finasteride effectively treats male hair loss, improving growth and density.

research Effects of Finasteride (MK-906), a 5α-Reductase Inhibitor, on Circulating Androgens in Male Volunteers

147 citations, April 1990 in “The Journal of Clinical Endocrinology and Metabolism”

Finasteride safely lowers DHT levels without affecting testosterone.

Similar Research

5 / 1000+ results

research Long-Acting Microneedle Formulations

1 citations, August 2023 in “Advanced Drug Delivery Reviews”

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

research A Microfluidic Application for Mass Production of Drug-Loaded Polymeric Microspheres for a Long-Acting Injectable With IVL-DrugFluidic, a Novel Microfluidic Microsphere Manufacturing Platform Technology

April 2023 in “OpenNano”

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia

research A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia

June 2024 in “Advances in therapy”

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

research Pharmacodynamic Evaluation: Endocrinology

January 2017

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

research Androgens and Cardiovascular Disease

658 citations, June 2003 in “Endocrine reviews”

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Pharmacokinetic-Pharmacodynamic Modeling Approach for Dose Prediction of the Optimal Long-Acting Injectable Formulation of Finasteride

Research cited in this study

research Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date

research Optimization of Microstructured Biodegradable Finasteride Formulation for Depot Parenteral Application

research Assessment of the Usefulness of Dihydrotestosterone in the Diagnostics of Patients with Androgenetic Alopecia

research Finasteride, a Type 2 5α-Reductase Inhibitor, in the Treatment of Men with Androgenetic Alopecia

research Effects of Finasteride (MK-906), a 5α-Reductase Inhibitor, on Circulating Androgens in Male Volunteers

Related Community Posts Join

community 5% Minoxidil after 4 months - started with twice a day but went down to once because I kept forgetting in the morning. Really happy with how it is going!

community DIY treatment... Shedding completely stopped after 1.5 yrs

community If you’re sitting there wondering, “I’m losing my hair, what do I do?” then read my advice here. I’ve been fighting the fight for 7 years, with great success. (pictures included)

community Some tips & advice from a long term finasteride + minoxidil user.

community My Testosterone is less than 1/3rd In 7 Months since I took Finasteride!